GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProText Mobility Inc (OTCPK:TXTM) » Definitions » Cyclically Adjusted PS Ratio

ProText Mobility (ProText Mobility) Cyclically Adjusted PS Ratio : (As of Jun. 06, 2024)


View and export this data going back to 2003. Start your Free Trial

What is ProText Mobility Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


ProText Mobility Cyclically Adjusted PS Ratio Historical Data

The historical data trend for ProText Mobility's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProText Mobility Cyclically Adjusted PS Ratio Chart

ProText Mobility Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

ProText Mobility Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of ProText Mobility's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, ProText Mobility's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ProText Mobility's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProText Mobility's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where ProText Mobility's Cyclically Adjusted PS Ratio falls into.



ProText Mobility Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

ProText Mobility's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2014 is calculated as:

For example, ProText Mobility's adjusted Revenue per Share data for the three months ended in Sep. 2014 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Sep. 2014 (Change)*Current CPI (Sep. 2014)
=0/100.4278*100.4278
=0.000

Current CPI (Sep. 2014) = 100.4278.

ProText Mobility Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
200412 0.000 80.290 0.000
200503 0.000 81.555 0.000
200506 4.184 82.062 5.120
200509 27.548 83.876 32.984
200512 9.044 83.032 10.939
200603 0.565 84.298 0.673
200606 0.489 85.606 0.574
200609 2.340 85.606 2.745
200612 3.426 85.142 4.041
200703 4.854 86.640 5.626
200706 -2.188 87.906 -2.500
200709 2.714 87.964 3.099
200712 0.480 88.616 0.544
200803 1.151 90.090 1.283
200806 0.099 92.320 0.108
200809 1.155 92.307 1.257
200812 0.989 88.697 1.120
200903 0.098 89.744 0.110
200906 0.086 91.003 0.095
200909 0.082 91.120 0.090
200912 0.058 91.111 0.064
201003 0.079 91.821 0.086
201006 0.064 91.962 0.070
201009 0.054 92.162 0.059
201012 0.036 92.474 0.039
201103 0.032 94.283 0.034
201106 0.034 95.235 0.036
201109 0.029 95.727 0.030
201112 0.037 95.213 0.039
201203 0.027 96.783 0.028
201206 0.010 96.819 0.010
201209 0.007 97.633 0.007
201212 0.003 96.871 0.003
201303 0.000 98.209 0.000
201306 0.000 98.518 0.000
201309 0.000 98.790 0.000
201312 0.000 98.326 0.000
201403 0.000 99.695 0.000
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


ProText Mobility  (OTCPK:TXTM) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


ProText Mobility Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of ProText Mobility's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


ProText Mobility (ProText Mobility) Business Description

Traded in Other Exchanges
N/A
Address
One West Las Olas Boulevard, Suite 500, Fort Lauderdale, FL, USA, 33301
ProText Mobility Inc is a Biotech Company developing a Hemp/CBD - Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes & technologies. Protext has engaged in the research, testing, and development of bioavailable botanical products all-natural ingredients formulated for nutraceuticals and pharmaceutical applications through proprietary live plant extraction technology.
Executives
Peter Sealey director 37400 CENTRAL COURT, NEWARK CA 94560

ProText Mobility (ProText Mobility) Headlines

From GuruFocus